Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer

Update Il y a 4 ans
Reference: EUCTR2009-017591-24

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the study is to evaluate the anti-tumor activity of LY2181308 in combination with docetaxel therapy (experimental arm) compared to docetaxel alone (control or standard-of-care arm) in second line Non Small Cell Lung Cancer (NSCLC) patients.


Inclusion criteria

  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer